Skip to main content
. 2019 Sep 4;6(9):ofz228. doi: 10.1093/ofid/ofz228

Table 1.

Demographics and Baseline Characteristics

Active (n = 130) Placebo (n = 130) Overall (n = 260) P a
Demographics and behavioral
Age, yb 67.8 (65.1–71.5) 69.0 (65.4–73.4) 68.2 (65.4–72.5) .251
BMI, kg/m2b 30.2 (26.4–34.6) 30.0 (26.8–33.9) 30.1 (26.6–34.1) .867
Calcium intake, mgb 842.0 (600–1142) 826.5 (628.0–1185) 828.0 (614.0–1164) .857
Laboratory
25(OH)D3, ng/mL 21.5 ± 6.5 22.2 ± 6.9 21.8 ± 6.7 .352
PTH, pg/mLb 56.1 (41.0–73.6) 56.4 (39.5–73.8) 56.2 (39.8–73.8) .977
Serum Ca, mg/dLb 9.5 (9.3–9.8) 9.5 (9.3–9.8) 9.5 (9.3–9.8) .943
Serum Cr, mg/dLb 0.8 (0.7–0.9) 0.7 (0.6–0.9) 0.8 (0.6–0.9) .472
Free 25(OH)D, pg/mL 4.7 ± 1.2 4.8 ± 1.3 4.7 ± 1.3 .565
1, 25(OH)2D3, pg/mL 52.4 ± 13.7 52.6 ± 15.4 52.5 ± 14.6 .926

Normally distributed variables are presented as mean ± SD, and non–normally distributed variables are presented as median (IQR).

Abbreviations: BMI, body mass index; IQR, interquartile range.

aFor continuous data, P values are from a Wilcoxon rank-sum test for non–normally distributed variables and a 2 independent-samples t test for normally distributed variables. For categorical variables, P values are from the Fisher exact test.

bNon–normally distributed.